These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31654986)

  • 21. Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn's disease.
    Douglas GM; Hansen R; Jones CMA; Dunn KA; Comeau AM; Bielawski JP; Tayler R; El-Omar EM; Russell RK; Hold GL; Langille MGI; Van Limbergen J
    Microbiome; 2018 Jan; 6(1):13. PubMed ID: 29335008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease progression-associated alterations in fecal metabolites in SAMP1/YitFc mice, a Crohn's disease model.
    Komatsu Y; Shimizu Y; Yamano M; Kikuchi M; Nakamura K; Ayabe T; Aizawa T
    Metabolomics; 2020 Apr; 16(4):48. PubMed ID: 32274593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Gut Microbiome of Pediatric Crohn's Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response.
    Dunn KA; Moore-Connors J; MacIntyre B; Stadnyk A; Thomas NA; Noble A; Mahdi G; Rashid M; Otley AR; Bielawski JP; Van Limbergen J
    Inflamm Bowel Dis; 2016 Nov; 22(11):2607-2618. PubMed ID: 27760077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease.
    Strömbeck A; Lasson A; Strid H; Sundin J; Stotzer PO; Simrén M; Magnusson MK; Öhman L
    BMC Gastroenterol; 2020 May; 20(1):130. PubMed ID: 32366222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in fecal microbiota and metabolomics in a child with juvenile idiopathic arthritis (JIA) responding to two treatment periods with exclusive enteral nutrition (EEN).
    Berntson L; Agback P; Dicksved J
    Clin Rheumatol; 2016 Jun; 35(6):1501-6. PubMed ID: 27021336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced microbiota profiling in patients with quiescent Crohn's disease through comparison with paired healthy first-degree relatives.
    Chen W; Li Y; Wang W; Gao S; Hu J; Xiang B; Wu D; Jiao N; Xu T; Zhi M; Zhu L; Zhu R
    Cell Rep Med; 2024 Jul; 5(7):101624. PubMed ID: 38942021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
    Tan AH; Chong CW; Lim SY; Yap IKS; Teh CSJ; Loke MF; Song SL; Tan JY; Ang BH; Tan YQ; Kho MT; Bowman J; Mahadeva S; Yong HS; Lang AE
    Ann Neurol; 2021 Mar; 89(3):546-559. PubMed ID: 33274480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metagenomic Analysis of Crohn's Disease Patients Identifies Changes in the Virome and Microbiome Related to Disease Status and Therapy, and Detects Potential Interactions and Biomarkers.
    Pérez-Brocal V; García-López R; Nos P; Beltrán B; Moret I; Moya A
    Inflamm Bowel Dis; 2015 Nov; 21(11):2515-32. PubMed ID: 26313691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysbiosis of the fecal microbiota in the TNBS-induced Crohn's disease mouse model.
    He Q; Li X; Liu C; Su L; Xia Z; Li X; Li Y; Li L; Yan T; Feng Q; Xiao L
    Appl Microbiol Biotechnol; 2016 May; 100(10):4485-94. PubMed ID: 26795965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
    Suskind DL; Brittnacher MJ; Wahbeh G; Shaffer ML; Hayden HS; Qin X; Singh N; Damman CJ; Hager KR; Nielson H; Miller SI
    Inflamm Bowel Dis; 2015 Mar; 21(3):556-63. PubMed ID: 25647155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection.
    Antharam VC; McEwen DC; Garrett TJ; Dossey AT; Li EC; Kozlov AN; Mesbah Z; Wang GP
    PLoS One; 2016; 11(2):e0148824. PubMed ID: 26871580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stool metabolome-microbiota evaluation among children and adolescents with obesity, overweight, and normal-weight using 1H NMR and 16S rRNA gene profiling.
    Jaimes JD; Slavíčková A; Hurych J; Cinek O; Nichols B; Vodolánová L; Černý K; Havlík J
    PLoS One; 2021; 16(3):e0247378. PubMed ID: 33765008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease.
    Wedenoja S; Saarikivi A; Mälkönen J; Leskinen S; Lehto M; Adeshara K; Tuokkola J; Nikkonen A; Merras-Salmio L; Höyhtyä M; Hörkkö S; Haaramo A; Salonen A; de Vos WM; Korpela K; Kolho KL
    PLoS One; 2022; 17(6):e0269561. PubMed ID: 35679312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Microbiome and Metabolome of Preterm Infant Stool Are Personalized and Not Driven by Health Outcomes, Including Necrotizing Enterocolitis and Late-Onset Sepsis.
    Wandro S; Osborne S; Enriquez C; Bixby C; Arrieta A; Whiteson K
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metaproteomics reveals persistent and phylum-redundant metabolic functional stability in adult human gut microbiomes of Crohn's remission patients despite temporal variations in microbial taxa, genomes, and proteomes.
    Blakeley-Ruiz JA; Erickson AR; Cantarel BL; Xiong W; Adams R; Jansson JK; Fraser CM; Hettich RL
    Microbiome; 2019 Feb; 7(1):18. PubMed ID: 30744677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.
    De Cruz P; Kang S; Wagner J; Buckley M; Sim WH; Prideaux L; Lockett T; McSweeney C; Morrison M; Kirkwood CD; Kamm MA
    J Gastroenterol Hepatol; 2015 Feb; 30(2):268-78. PubMed ID: 25087692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential clustering of fecal and mucosa-associated microbiota in 'healthy' individuals.
    Carstens A; Roos A; Andreasson A; Magnuson A; Agréus L; Halfvarson J; Engstrand L
    J Dig Dis; 2018 Dec; 19(12):745-752. PubMed ID: 30467977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
    Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in microbiome and metabolomic profiles of fecal samples stored with stabilizing solution at room temperature: a pilot study.
    Lim MY; Hong S; Kim BM; Ahn Y; Kim HJ; Nam YD
    Sci Rep; 2020 Feb; 10(1):1789. PubMed ID: 32019987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.